What are the two types of craniopharyngiomas (brain tumors)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

The two types of craniopharyngiomas are adamantinomatous and papillary craniopharyngiomas, as identified in the most recent study 1. These two types differ in their histological appearance and genetic profiles.

  • Adamantinomatous craniopharyngiomas are more common in children and are characterized by their calcifications, cystic components, and finger-like projections that can infiltrate surrounding brain tissue.
  • Papillary craniopharyngiomas, on the other hand, are more commonly found in adults and have a more solid appearance with less calcification. They tend to be more well-circumscribed and less invasive than the adamantinomatous type. The genetic profiles of these two types also differ, with adamantinomatous craniopharyngiomas often showing CTNNB1 gene mutations affecting beta-catenin, while papillary variants typically have BRAF V600E mutations, as supported by recent studies 1, 2. Understanding the type of craniopharyngioma is important for treatment planning and predicting behavior, though both types are benign tumors that develop near the pituitary gland and hypothalamus, as discussed in various studies 3, 4. The identification of these two types has significant implications for the management and treatment of craniopharyngiomas, with targeted therapies representing a significant advancement in the field of oncology, as highlighted in the most recent study 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.